• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常染色体显性遗传多囊肾病患者颅内动脉瘤破裂风险的相关临床因素。

Clinical Factors Associated with the Risk of Intracranial Aneurysm Rupture in Autosomal Dominant Polycystic Kidney Disease.

机构信息

Department of Neurology, Jeonbuk National University Hospital and Medical School, Jeonju, Republic of Korea.

Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital, Jeonju, Republic of Korea.

出版信息

Cerebrovasc Dis. 2021;50(3):339-346. doi: 10.1159/000513709. Epub 2021 Mar 11.

DOI:10.1159/000513709
PMID:33706308
Abstract

BACKGROUND

The occurrence of intracranial aneurysms is higher in patients with autosomal dominant polycystic kidney disease (ADPKD) than in the healthy population. However, research concerning the factors related to the risk of intracranial aneurysm rupture in patients with ADPKD is still insufficient.

OBJECTIVES

The aim of the study was to investigate the prevalence of intracranial aneurysms and aneurysmal subarachnoid hemorrhage (SAH) and to analyze the systemic factors associated with high-risk aneurysms in patients with ADPKD.

METHODS

We screened patients who underwent cerebral angiography between January 2007 and May 2017 in the ADPKD registry. Patients were examined for the presence of intracranial aneurysms and subsequently reclassified into 3 groups based on the risk of aneurysmal rupture: the aneurysm-negative (group 1), low-risk aneurysm (group 2), or high-risk aneurysm (group 3). Various systemic factors were compared, and independent factors associated with high-risk aneurysms were analyzed.

RESULTS

Among the 926 patients, 148 (16.0%) had intracranial aneurysms and 11 (1.2%) had previous aneurysmal SAH. Patients with intracranial aneurysms were further classified into group 2 (low-risk aneurysms, 15.5%) or group 3 (high-risk aneurysms, 84.5%). Age (odds ratio [OR] 1.03, 95% confidence interval [CI] 1.01-1.05, p = 0.004), female sex (OR 3.13, 95% CI 1.94-5.0 6, p < 0.001), dolichoectasia (OR 8.57, 95% CI 1.53-48.17, p = 0.015), and mitral inflow deceleration time (DT) (OR 1.01, 95% CI 1.00-1.01, p = 0.046) were independently associated with high-risk aneurysms, whereas hypercholesterolemia (OR 0.46, 95% CI 0.29-0.72, p = 0.001) was negatively associated.

CONCLUSION

In the present study among patients with ADPKD, the prevalence of intracranial aneurysms and aneurysmal SAH was 16 and 1.2%, respectively. Age, female sex, dolichoectasia, and mitral inflow DT were positively associated with high-risk aneurysms, whereas hypercholesterolemia was negatively associated. A subsequent large-scaled longitudinal study is needed to define the plausibility of the clinical parameters.

摘要

背景

常染色体显性多囊肾病(ADPKD)患者颅内动脉瘤的发生率高于健康人群。然而,关于 ADPKD 患者颅内动脉瘤破裂风险相关因素的研究仍不够充分。

目的

本研究旨在探讨 ADPKD 患者颅内动脉瘤及蛛网膜下腔出血(SAH)的患病率,并分析与颅内动脉瘤高危相关的系统性因素。

方法

我们对 2007 年 1 月至 2017 年 5 月期间在 ADPKD 登记处行脑血管造影的患者进行了筛选。对患者进行颅内动脉瘤的检查,随后根据动脉瘤破裂的风险将患者重新分为 3 组:无动脉瘤(第 1 组)、低危动脉瘤(第 2 组)或高危动脉瘤(第 3 组)。比较了各种系统性因素,并分析了与高危动脉瘤相关的独立因素。

结果

在 926 例患者中,148 例(16.0%)存在颅内动脉瘤,11 例(1.2%)存在既往动脉瘤性 SAH。颅内动脉瘤患者进一步分为第 2 组(低危动脉瘤,15.5%)或第 3 组(高危动脉瘤,84.5%)。年龄(比值比[OR]1.03,95%置信区间[CI]1.01-1.05,p=0.004)、女性(OR 3.13,95%CI 1.94-5.06,p<0.001)、梭形动脉瘤(OR 8.57,95%CI 1.53-48.17,p=0.015)和二尖瓣流入减速时间(DT)(OR 1.01,95%CI 1.00-1.01,p=0.046)与高危动脉瘤独立相关,而高胆固醇血症(OR 0.46,95%CI 0.29-0.72,p=0.001)与高危动脉瘤负相关。

结论

在本研究中,ADPKD 患者颅内动脉瘤和动脉瘤性 SAH 的患病率分别为 16%和 1.2%。年龄、女性、梭形动脉瘤和二尖瓣流入 DT 与高危动脉瘤呈正相关,而高胆固醇血症与高危动脉瘤呈负相关。需要进一步进行大规模的纵向研究来确定这些临床参数的可能性。

相似文献

1
Clinical Factors Associated with the Risk of Intracranial Aneurysm Rupture in Autosomal Dominant Polycystic Kidney Disease.常染色体显性遗传多囊肾病患者颅内动脉瘤破裂风险的相关临床因素。
Cerebrovasc Dis. 2021;50(3):339-346. doi: 10.1159/000513709. Epub 2021 Mar 11.
2
Is Regular Screening for Intracranial Aneurysm Necessary in Patients with Autosomal Dominant Polycystic Kidney Disease? A Systematic Review and Meta-analysis.常染色体显性多囊肾病患者是否需要定期进行颅内动脉瘤筛查?一项系统评价和荟萃分析。
Cerebrovasc Dis. 2017;44(1-2):75-82. doi: 10.1159/000476073. Epub 2017 May 13.
3
Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease.常染色体显性多囊肾病患者颅内动脉瘤的无症状筛查。
Clin J Am Soc Nephrol. 2019 Aug 7;14(8):1151-1160. doi: 10.2215/CJN.14691218. Epub 2019 Jul 30.
4
Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review.常染色体显性多囊肾病患者的颅内动脉瘤:患病率、破裂风险及管理。一项系统评价。
Acta Neurochir (Wien). 2017 May;159(5):811-821. doi: 10.1007/s00701-017-3142-z. Epub 2017 Mar 10.
5
Clinical relevance of short-term follow-up of unruptured intracranial aneurysms.未破裂颅内动脉瘤的短期随访的临床意义。
Neurosurg Focus. 2019 Jul 1;47(1):E7. doi: 10.3171/2019.4.FOCUS1995.
6
Intracranial aneurysms in patients receiving kidney transplantation for autosomal dominant polycystic kidney disease.常染色体显性多囊肾病患者接受肾移植术后的颅内动脉瘤。
Acta Neurochir (Wien). 2019 Nov;161(11):2389-2396. doi: 10.1007/s00701-019-04060-7. Epub 2019 Sep 9.
7
Preventive screening for intracranial aneurysms.颅内动脉瘤的预防性筛查。
Int J Stroke. 2022 Jan;17(1):30-36. doi: 10.1177/17474930211024584. Epub 2021 Jun 17.
8
Screening for intracranial aneurysms in autosomal dominant polycystic kidney disease is cost-effective.在常染色体显性多囊肾病中筛查颅内动脉瘤具有成本效益。
Kidney Int. 2018 Mar;93(3):716-726. doi: 10.1016/j.kint.2017.08.016. Epub 2017 Oct 20.
9
Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.与常染色体显性多囊肾病患者早发性颅内动脉瘤相关的因素。
J Nephrol. 2024 May;37(4):983-992. doi: 10.1007/s40620-023-01866-8. Epub 2024 Feb 5.
10
Prevalence and risk of rupture of intracranial aneurysms: a systematic review.颅内动脉瘤的患病率及破裂风险:一项系统评价
Stroke. 1998 Jan;29(1):251-6. doi: 10.1161/01.str.29.1.251.

引用本文的文献

1
Risk factors for cerebral vasospasm following arteriovenous malformation-related hemorrhage: a systematic review and meta-analysis.动静脉畸形相关出血后脑血管痉挛的危险因素:一项系统评价和荟萃分析
Neurosurg Rev. 2025 Jul 2;48(1):540. doi: 10.1007/s10143-025-03684-x.
2
Risk factors and predictive indicators of rupture in cerebral aneurysms.脑动脉瘤破裂的危险因素及预测指标
Front Physiol. 2024 Sep 5;15:1454016. doi: 10.3389/fphys.2024.1454016. eCollection 2024.
3
Intracranial aneurysm rupture risk in northern China: a retrospective case-control study.
中国北方颅内动脉瘤破裂风险:一项回顾性病例对照研究。
Quant Imaging Med Surg. 2024 Jan 3;14(1):376-385. doi: 10.21037/qims-23-820. Epub 2023 Nov 17.
4
A Review of Artificial Intelligence in the Rupture Risk Assessment of Intracranial Aneurysms: Applications and Challenges.颅内动脉瘤破裂风险评估中的人工智能综述:应用与挑战
Brain Sci. 2023 Jul 11;13(7):1056. doi: 10.3390/brainsci13071056.
5
Surgical Management of Autosomal Dominant Polycystic Kidney Disease: Principles and Current Practice.常染色体显性遗传性多囊肾病的外科治疗:原则与现状。
JNMA J Nepal Med Assoc. 2023 May 1;61(261):485-491. doi: 10.31729/jnma.8159.
6
Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease.肾功能和肾体积对常染色体显性多囊肾病患者颅内动脉瘤的影响。
Sci Rep. 2022 Oct 27;12(1):18056. doi: 10.1038/s41598-022-22884-9.